TrialNCT06209736Phase 2Recruiting
Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN
Study sponsor: Omeros Corporation
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2026-01Estimated
Enrollment · participants20Estimated
Source updated2025-07-15Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.